Scientific American editors recommended that the US government reclassify psychedelic drugs to the less strict Schedule II classification to facilitate clinical research into their effects.

Authors

• Person: Not available Organization: UC Berkeley Center for the Science of Psychedelics
  history Archives - UC Berkeley Center for the Science of Psychedelics

Sources

• history Archives - UC Berkeley Center for the Science of Psychedelics psychedelics.berkeley.edu UC Berkeley Center for the Science of Psychedelics via serper

Referenced by nodes (2)

• United States federal government entity
• Scientific American entity